Washington [US], April 10 (ANI): Researchers found out how chronic infection with the hepatitis B virus (HBV) causes gradual liver damage, and eradicating the virus remains a daunting challenge.

According to new research published in FEBS Letters, therapy that amplifies the impact of immune cells known as stem cell memory T cells (TSCMs) could be a promising technique for treating HBV.

Also Read | Meta Llama 3 AI Model To Launch Soon; Know What To Expect From Upcoming Gen-AI Model From Meta.

In the study, investigators identified TSCMs in patients with chronic HBV infection and analyzed their effects in a mouse model of HBV. After introducing TSCMs from patients into the mice, the immune cells differentiated into cytotoxic T cells and activated a strong response that resulted in the elimination of HBV-infected liver cells. Therefore, augmenting patients' TSCMs may help the immune system overcome the virus.

"Our hepatitis model may reveal how TSCMs differentiate into cytotoxic T cells and uncover the fate of differentiated T cells. Such information could greatly advance future research on T cell-based therapies," said corresponding author Hiromi Abe-Chayama, PhD, of Hiroshima University, in Japan. (ANI)

Also Read | Online Fraud in Mumbai: Accountant Cheats Office of Rs One Crore, Loses It All in 'Double Your Money' Scheme; Probe Launched.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)